ENTERICA
Dead / Abandoned — Abandoned — failure to respond (as of 24 Mar 2025)
What this means for you
This application is over — abandoned 28 Feb 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 98208262
- Mark type
- Stylized text
- Filed
- 03 Oct 2023
- Abandoned
- 28 Feb 2025
- Attorney of record
- Kevin M. Bovard
Goods and services
- Class 005 — Pharmaceuticals: Therapeutic agent, namely, chemicals in the nature of internally administered therapeutic sorbents in the form of synthetic, polymeric, and processed natural materials for pharmaceutical purposes that reduce cytokines, toxins, bile acids, and other inflammatory mediators intraluminally to treat both local and systemic inflammation and tissue injury.
Owner
- CYTOSORBENTS CORPORATION, Princeton, NJ, US
Prosecution history
- 24 Mar 2025 — ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
- 24 Mar 2025 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 27 Nov 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 27 Nov 2024 — FINAL REFUSAL E-MAILED
- 27 Nov 2024 — FINAL REFUSAL WRITTEN
- 25 Nov 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 25 Nov 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 25 Nov 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 23 Aug 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 23 Aug 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 23 May 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 23 May 2024 — NON-FINAL ACTION E-MAILED
- 23 May 2024 — NON-FINAL ACTION WRITTEN
- 23 May 2024 — ASSIGNED TO EXAMINER
- 14 Oct 2023 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED